**Purpose:** A mainstay of reconstructive surgery is breast reconstruction following mastectomy. While an anatomic resection would typically follow the breast capsule, both under- and over- resection of tissue is possible due to the similarity of breast tissue and adipose tissue. Under-resection leaves the possibility of recurrent breast cancer while over-resection results in thin or non-viable mastectomy skin flaps. The goals of this study were to engineer a sensitive and specific breast tissue marker and to create a model for administration of the marker.

**Methods:** Using 3 immortal cell lines we applied a two-antibody-enzyme system against mammaglobin with a colorimetric signal to evaluate the appropriateness of using mammaglobin as our target. We then applied our two-antibody system using immunofluorescence towards breast tissue collected from breast reduction specimens to show that it can target mammaglobin-positive cells. Confocal microscopy was used to confirm specific binding on the cell surface of breast tissue.

**Results:** The two-antibody-enzyme conjugate successfully produced a colorimetric signal to label breast tissue in cell culture. A primary goat antibody targeting mammoglobin was used along with a secondary anti-goat antibody. The anti-goat antibody was labeled with a pink fluorescent marker for confocal microscopy and with biotin-streptavidin conjugate for the colorimetric change.

**Conclusions:** This study shows that mammoglobin is a viable target for breast tissue labeling. This could serve as an ideal marker for reducing the risk of under and over resection of breast tissue during mastectomy surgery.
